Below content

GeoPolitics Pulse

  • Middle East
    • Israel
    • Lebanon
    • Qatar
    • Saudi Arabia
    • Syria
    • Iraq
    • Iran
    • Turkey
  • Russia
    • Armenia
  • Asia
    • India
    • China
    • Taiwan
    • Singapore
    • Japan
    • North Korea
    • South Korea
  • Africa
  • Western Europe
    • European union
    • Germany
    • Italy
    • United Kingdom
    • France
  • Eastern Europe
    • Czechia
    • Slovakia
    • Poland
    • Hungary
    • Romania
    • Ukraine
  • America
  • Finance
    • Gold
    • Global Debt
    • BRICS
    • World Economic Forum
  • Technology
    • Amazon
    • Starbucks
    • Tesla
    • Nvidia
    • Instagram
    • Meta
    • Microsoft
    • Google
    • ChatGPT
    • Artificial Intelligence
    • Apple
    • Transhumanism
  • Australia

GeoPolitics Pulse

The Heartbeat of World events

  • Middle East
    • Israel
    • Lebanon
    • Qatar
    • Saudi Arabia
    • Syria
    • Iraq
    • Iran
    • Turkey
  • Russia
    • Armenia
  • Asia
    • India
    • China
    • Taiwan
    • Singapore
    • Japan
    • North Korea
    • South Korea
  • Africa
  • Western Europe
    • European union
    • Germany
    • Italy
    • United Kingdom
    • France
  • Eastern Europe
    • Czechia
    • Slovakia
    • Poland
    • Hungary
    • Romania
    • Ukraine
  • America
  • Finance
    • Gold
    • Global Debt
    • BRICS
    • World Economic Forum
  • Technology
    • Amazon
    • Starbucks
    • Tesla
    • Nvidia
    • Instagram
    • Meta
    • Microsoft
    • Google
    • ChatGPT
    • Artificial Intelligence
    • Apple
    • Transhumanism
  • Australia
  • Eastern Europe / European union / Western Europe

Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s …

by Editor · April 16, 2025

… European Union. Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union …Read More

Related posts:

  1. Leqembi®∇ (lecanemab) is the First Medicine that Slows – GlobeNewswire
  2. Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
  3. Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
  4. Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early … – Nasdaq
  5. Update on regulatory review of lecanemab for treatment of early Alzheimer’s disease in the …
  • Next story Leqembi®∇ (lecanemab) is the First Medicine that Slows – GlobeNewswire
  • Previous story Renewed concern over direction of EU climate policy in wake of alarming 2024 weather report

RSS BBC World News feed

  • US lawmakers threaten legal action against Attorney General over Epstein files
  • US pursuing third oil tanker linked to Venezuela, official says
  • Baby followed by BBC back in Gaza hospital after treatment abroad

RSS Sky World News feed

  • Russian general killed by car bomb and Moscow blames Ukraine
  • Russian general assassinated - here's why the timing appears significant
  • Trump's new Greenland envoy intends to make territory 'a part of the US'

RSS Al Jazeera News feed

  • UPS stumbles into holiday season amid shifting trade rules
  • Srebrenica: Genocide on Trial
  • Trump pauses more offshore wind projects citing national security concerns

RSS Iran News

  • Iran's Tractor beats Qatar's Duhail in AFC Champions League
  • Pezeshkian stresses boosting Iran-Georgia coop. in Caucasus
  • Fierce clashes reported btw HTS-led regime forces and SDF

GeoPolitics Pulse © 2025. All Rights Reserved.

Powered by  - Designed with the Go Hueman Pro